AR065468A1 - Derivados de nevirapina inhibidores de la transcriptasa reversa - Google Patents
Derivados de nevirapina inhibidores de la transcriptasa reversaInfo
- Publication number
- AR065468A1 AR065468A1 ARP080100774A ARP080100774A AR065468A1 AR 065468 A1 AR065468 A1 AR 065468A1 AR P080100774 A ARP080100774 A AR P080100774A AR P080100774 A ARP080100774 A AR P080100774A AR 065468 A1 AR065468 A1 AR 065468A1
- Authority
- AR
- Argentina
- Prior art keywords
- nevirapine
- reverse transcript
- deuterium
- derivatives inhibitors
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Reivindicacion 1: Un compuesto caracterizado porque tiene la Formula estructural (1) o una sal, solvato, o profármaco farmacéuticamente aceptable del mismo; caracterizado porque: R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, y R14 seseleccionan independientemente del grupo que consiste de hidrogeno y deuterio; al menos uno de R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, y R14 es deuterio; y cuando R3, R4, y R5 son deuterio luego al menos uno de R1, R2, R6, R7, R8,R9, R10, R11, R12, R13, y R14 es deuterio.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89143607P | 2007-02-23 | 2007-02-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR065468A1 true AR065468A1 (es) | 2009-06-10 |
Family
ID=39615861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080100774A AR065468A1 (es) | 2007-02-23 | 2008-02-25 | Derivados de nevirapina inhibidores de la transcriptasa reversa |
Country Status (4)
Country | Link |
---|---|
US (1) | US20080241289A1 (es) |
AR (1) | AR065468A1 (es) |
TW (1) | TW200835693A (es) |
WO (1) | WO2008103899A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2774999A1 (en) | 2009-09-30 | 2011-04-07 | President And Fellows Of Harvard College | Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products |
WO2011041512A2 (en) * | 2009-10-02 | 2011-04-07 | Emory University | Compositions and methods for treating mlv-infection, and preventing and treating mlv-initiated diseases |
BR112012011095A2 (pt) * | 2009-11-10 | 2015-10-06 | Univ Northwest | método para aumentar a solubilidade de uma composição inibidora de transcriptase |
ES2969969T3 (es) | 2010-01-27 | 2024-05-23 | Viiv Healthcare Co | Combinaciones de dolutegravir y lamivudina para el tratamiento de la infección por VIH |
CN111423456A (zh) * | 2020-04-03 | 2020-07-17 | 南京昊绿生物科技有限公司 | 一种利福昔明-d6的合成工艺 |
JP2023529834A (ja) * | 2020-06-04 | 2023-07-12 | ザ ジェネラル ホスピタル コーポレイション | コロナウイルス感染症を治療する方法 |
EP4376867A1 (en) * | 2021-07-28 | 2024-06-05 | University Of Louisville Research Foundation, Inc. | Anti-fungal griffithsin compostions and methods of use |
CN115028577A (zh) * | 2022-06-24 | 2022-09-09 | 盐城迪赛诺制药有限公司 | 一种2-氯-n-(2-氯-4-甲基吡啶-3-基)烟酰胺的提纯方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5366972A (en) * | 1989-04-20 | 1994-11-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection |
EP1134290A3 (en) * | 2000-03-14 | 2004-01-02 | Pfizer Products Inc. | Pharmacophore models for the identification of the CYP2D6 inhibitory potency of selective serotonin reuptake inhibitors |
US20080033011A1 (en) * | 2005-07-29 | 2008-02-07 | Concert Pharmaceuticals Inc. | Novel benzo[d][1,3]-dioxol derivatives |
US7696165B2 (en) * | 2006-03-28 | 2010-04-13 | Albany Molecular Research, Inc. | Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders |
US7696166B2 (en) * | 2006-03-28 | 2010-04-13 | Albany Molecular Research, Inc. | Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders |
US20070232532A1 (en) * | 2006-03-28 | 2007-10-04 | Amr Technology, Inc. | Use of cyclosporin alkene analogues for preventing or treating viral-induced disorders |
WO2008063600A2 (en) * | 2006-11-17 | 2008-05-29 | Concert Pharmaceuticals Inc. | Triazolyl tropane derivatives |
WO2008077103A1 (en) * | 2006-12-19 | 2008-06-26 | Auspex Pharmaceuticals, Inc. | Preperation and utility of ccr5 inhibitors |
ES2356334T3 (es) * | 2007-06-12 | 2011-04-07 | Concert Pharmaceuticals, Inc. | Derivados de azapéptidos como inhibidores de la proteasa vih. |
US20080318904A1 (en) * | 2007-06-20 | 2008-12-25 | Protia, Llc | Deuterium-enriched tenofovir |
US20090075991A1 (en) * | 2007-09-14 | 2009-03-19 | Protia, Llc | Deuterium-enriched efavirenz |
US20090076138A1 (en) * | 2007-09-15 | 2009-03-19 | Protia, Llc | Deuterium-enriched darunavir |
US8410124B2 (en) * | 2007-10-18 | 2013-04-02 | Concert Pharmaceuticals Inc. | Deuterated etravirine |
-
2008
- 2008-02-22 WO PCT/US2008/054708 patent/WO2008103899A1/en active Application Filing
- 2008-02-22 US US12/035,763 patent/US20080241289A1/en not_active Abandoned
- 2008-02-22 TW TW097106313A patent/TW200835693A/zh unknown
- 2008-02-25 AR ARP080100774A patent/AR065468A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2008103899A1 (en) | 2008-08-28 |
TW200835693A (en) | 2008-09-01 |
US20080241289A1 (en) | 2008-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR065468A1 (es) | Derivados de nevirapina inhibidores de la transcriptasa reversa | |
AR106942A2 (es) | Compuestos de isoindolina y composiciones farmacéuticas de los mismos | |
AR106237A2 (es) | Inhibidores heterocíclicos de la aspartil proteasa, sus sales farmacéuticamente aceptables | |
ES2546515T3 (es) | Nuevo compuesto péptido cíclico, método para producirlo, agente anti-infeccioso, fracción que contiene antibiótico, antibiótico, método para producir antibiótico, microorganismo productor de antibiótico y antibiótico producido mediante el mismo | |
AR077695A1 (es) | Derivados de pirimidina como inhibidores del factor ixa | |
DE602006011752D1 (de) | Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate | |
AR083070A1 (es) | Analogos de nucleotidos sustituidos con heterociclos nitrogenados, composiciones farmaceuticas que los contienen y uso de los mismos para tratar enfermedades virales, en particular infecciones por vhc | |
RS54587B1 (en) | IMINOTIADIAZINE-DIOXIDE COMPOUNDS AS BACE, MIXTURE, AND USE INHIBITORS | |
MX2010003366A (es) | Derivados de piperidina y piperazina para el tratamiento de tumores. | |
NO20092279L (no) | Makrocyklisk factor VIIa inhibitorer anvendbare som antikoagulanter | |
AR049103A1 (es) | Derivados de piridazinona metodos para producirlos y su uso como productos farmaceuticos | |
AR073524A1 (es) | Piridopirimidinonas inhibidores de pi3k a y m tor | |
AR055592A1 (es) | Derivados de 2-amino-5-cicloalquil-hidantoina como moduladores y/o inhibidores de la beta-secretasa(bace) | |
ECSP099371A (es) | INHIBIDORES ESPIRO CETONA DE ACETIL-CoA CARBOXILASA | |
AR081058A1 (es) | Derivados de arilmetoxi isoindolina, composiciones que los comprenden y su uso en el tratamiento del cancer. | |
CL2009000228A1 (es) | Compuestos derivados de 7,8-dihidropirido[4,3-d]pirimidin con un sustituyente oximico, inhibidores de hsp90; y composicion farmaceutica que comprene a dichos compuestos. | |
MX2007016185A (es) | Inhibidores de aspartil proteasa heterociclicos macrociclicos. | |
CO6321230A2 (es) | Compuesto espiro, una sal aceptable para uso farmaceutico y un solvato del mismo y composicion farmaceutica que lo contenga | |
ATE553106T1 (de) | Heteroarylpyrrolopyridinone als kinaseinhibitoren | |
NO20063944L (no) | Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister | |
MY151986A (en) | Adamantyl diamide derivatives and uses of same | |
CR9214A (es) | 2-fenilindoles como antagonistas del receptor de la prostaglandina d2 | |
NO20092286L (no) | Nitrogenhaldige heterosykliske forbindelser og anvendelse derav | |
AR063805A1 (es) | Derivados de triazol sustituidos como inhibidores de ksp. composiciones farmaceuticas. | |
NO20090270L (no) | Cinnamoyl-piperazinederivater og deres anvendelse som PAR-I-antagonister |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |